HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Golbe, L. I. Search for Related Content PubMed PubMed Citation Articles by Golbe, L. I.

Parkinson's disease and pregnancy

Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ.

In an effort to study the interaction of pregnancy and Parkinson's disease (PD), I interviewed 18 women who had had a total of 24 pregnancies after onset of PD symptoms. Conception occurred at mean age 34.7 (SD 6.1) years. There were 3 miscarriages, 4 elective abortions, and 17 term pregnancies. Use of amantadine during the first trimester was associated with a heterogeneous group of obstetric complications including miscarriage. Ten of the 17 completed pregnancies were associated with permanent worsening of PD symptoms, which did not affect overall disability. Among the series as a whole there was no excess incidence of obstetric complications or fetal defects.

Address correspondence and reprint requests to Dr. Golbe, Department of Neurology, CN-19, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08903.

Presented in part at the thirty-eighth annual meeting of the American Academy of Neurology, New Orleans, LA, April 1986.

Received July 24, 1986. Accepted for publication in final form October 15, 1986.